Detalhe da pesquisa
1.
Structural and Catalytic Insight into the Unique Pentacyclic Triterpene Synthase TwOSC.
Angew Chem Int Ed Engl
; 62(48): e202313429, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840440
2.
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma.
J Hepatol
; 74(4): 907-918, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031845
3.
TeroKit: A Database-Driven Web Server for Terpenome Research.
J Chem Inf Model
; 60(4): 2082-2090, 2020 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286817
4.
HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells.
Cancer Sci
; 108(6): 1177-1184, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301080
5.
Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].
J Hepatol
; 77(2): 580, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489965
6.
Discovery of a SUCNR1 antagonist for potential treatment of diabetic nephropathy: In silico and in vitro studies.
Int J Biol Macromol
; 268(Pt 2): 131898, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677680
7.
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
Nat Commun
; 15(1): 1009, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307859
8.
Multiscale Simulations on the Catalytic Plasticity of CYP76AH1.
Front Chem
; 9: 689731, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34150721
9.
Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer.
Front Oncol
; 11: 615427, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33833984
10.
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer.
Oncogene
; 40(31): 4992-5001, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172932
11.
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.
Nat Commun
; 12(1): 2788, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986289
12.
Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.
Cancer Lett
; 482: 102-111, 2020 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705927
13.
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity.
Cancer Res
; 80(11): 2298-2310, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156778
14.
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.
Cancer Res
; 79(4): 819-829, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573522
15.
Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer.
Am J Cancer Res
; 8(9): 1837-1846, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323975
16.
Palmitoylation stabilizes PD-L1 to promote breast tumor growth.
Cell Res
; 29(1): 83-86, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514902